Agrochemical and agricultural biotechnology corporation Monsanto (MON) missed Wall Street profit forecast for its second quarter, while reporting a 6.6% growth in earnings, attributed mainly to newest soybean technologies, lower taxes and improved glyphosate pricing. Profit grew to $1.45 billion or $3.27 per share from the year ago profit of $1.36 billion or $3.09 per share. On an ongoing basis, EPS was $3.22, up 0.9% year-over-year.
Sales of the agricultural products company fell marginally by 1%, impacted by declining volumes and prices of its corn products, along with lower planted acerages. Monsanto reported revenue of $5.01 billion compared to $5.07 billion a year earlier. Shares of Monsanto increased slightly when the market opened today.
The St. Louis, Missouri-based company continues to be confident on closure of the merger with Bayer as both companies’ are on course to secure the required approvals within the second calendar quarter of 2018.
For fiscal 2018, the company expects pricing for glyphosate and the increased adoption of new technologies in Seeds and Genomics to drive growth. Monsanto is also confident of completing restructuring and cost savings initiative the company initiated a couple of years ago and expects its expenses to be down year-over-year. The company continues to expect pre-tax income growth for fiscal year 2018.
Latest economic data evoked mixed sentiment this week -- the rebound in economic activity has raised inflation concerns while jobless claims declined for the sixth week in a row. The
Video game retailer GameStop Corp. (NYSE: GME), which has become the talk of the town after the unprecedented stock rally in recent weeks, reported a narrower loss for the first
The steel industry managed to shrug off the pandemic blues earlier than expected as the recovery in industrial activity pushed up demand. With the vaccination drive and the government’s aggressive